By Priscila Mayumi Kashiwabara
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys at law Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2024 guide for Brazil, that outlines the regulatory framework for pharmaceuticals and medical devices, detailing the legislation, regulatory bodies and procedures for securing approvals and handling appeals. It covers categorisation, clinical trials, marketing authorizations and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, the stringent requirements for biologics and the procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations and measures against counterfeit products.
For more details, click here.
Share:
Last by Priscila Mayumi Kashiwabara
December 23, 2024
Brazilian court prohibits royalty collection for public domain technology
On the last working day of the Judiciary before the court recess (a period during which legal deadlines are suspended and no … Brazilian court prohibits royalty collection for public domain technology
December 2, 2024
Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
On November 27, 2024, the Chamber of Deputies approved Bill 466/2022, which addresses Brazil’s adhesion to the Budapest Treaty on the International … Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
September 23, 2024
Priscila Kashiwabara will be attending “From Gene to Trait 2024” course
Our partner Priscila Kashiwabara will be one of the speakers at the “From Gene to Trait 2024” course. The event will take … Priscila Kashiwabara will be attending “From Gene to Trait 2024” course